Viewing Study NCT05415332



Ignite Creation Date: 2024-05-06 @ 5:44 PM
Last Modification Date: 2024-10-26 @ 2:34 PM
Study NCT ID: NCT05415332
Status: RECRUITING
Last Update Posted: 2022-06-13
First Post: 2022-06-01

Brief Title: The Current Status and Clinical OUTcomes of Cardiogenic Shock Patients And the Role of Specialist in Cardiovascular Critical Care Unit
Sponsor: Yonsei University
Organization: Yonsei University

Study Overview

Official Title: The Current Status and Clinical OUTcomes of Cardiogenic Shock Patients And the Role of Specialist in Cardiovascular Critical Care Unit
Status: RECRUITING
Status Verified Date: 2022-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SCOUT SPARC
Brief Summary: In the case of cardiogenic shock the early mortality rate is the highest compared to other types of shock but it is characterized by a good prognosis and quality of life after recovery so monitoring the treatment progress is very important to identify the patients prognosis However there are few studies specifically reported on hemodynamic monitoring and prognosis of cardiogenic shock In addition as mechanical circulatory support devices are in the spotlight studies on their effects and safety are starting but studies on cardiogenic shock are often limited to patients with myocardial infarction

This study is a prospective and retrospective cohort observational study we aim to identify factors that can improve prognosis including various drug treatments diagnostic techniques and mechanical circulatory support device by investigating the treatment status and clinical outcomes of patients with cardiogenic shock hospitalized in cardiovascular critical care unit In addition the purpose of this study is to investigate the association between the prognosis of patients with cardiogenic shock and the presence of a specialist resident during regular work hours to clarify the role and necessity of a resident specialist in the cardiovascular intensive care unit

Furthermore by predicting and treating the clinical course of patients with cardiogenic shock at an early stage the aim is to reduce the mortality rate and improve the patients ability to perform daily activities
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None